SciELO - Scientific Electronic Library Online

 
vol.157 suppl.3Trasplante de células progenitoras hematopoyéticas (TCPH)en la era del COVID-19 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Gaceta médica de México

versión On-line ISSN 2696-1288versión impresa ISSN 0016-3813

Resumen

TREJO-GOMORA, Jorge  y  SALAZAR-BAILON, José. Transfusion Medicine in the COVID-19 Pandemic. The vision of the National Center of Blood Transfusion. Gac. Méd. Méx [online]. 2021, vol.157, suppl.3, pp.S151-S157.  Epub 25-Abr-2022. ISSN 2696-1288.  https://doi.org/10.24875/gmm.m21000474.

The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has put great pressure on health systems around the world. Experiences in previous outbreaks have taught us that when health systems are overwhelmed, mortality from diseases for which there are vaccines or treatments can also increase dramatically. During the 2014-2015 Ebola virus disease outbreak, the excess deaths from measles, malaria, HIV/AIDS, and tuberculosis attributable to the collapse of health systems exceeded that of Ebola deaths. For this reason, health systems should focus their efforts to maintain the continuity of care for essential medical services such as: the vaccination program, reproductive health services - which include care for pregnancy, childbirth and the immediate puerperium. - Health in childhood and the elderly, mental illnesses, chronic non-communicable diseases - including cancer and cardiovascular diseases - infectious diseases such as HIV, critical hospital treatments, treatment of urgent health problems and auxiliary services such as basic imaging diagnosis, laboratory services and blood banks. An organized and prepared health system is a system that has the necessary management to maintain the continuity of all those needs that require blood transfusion as part of essential treatment (oncological processes, care of obstetric hemorrhage, emergencies, trauma, symptomatic anemias and emergency surgeries) and of those other situations in which the transfusion of blood or a component is presented as a possible option for the treatment of patients with coronavirus disease 2019 (COVID-19) (convalescent plasma in research use).

Palabras llave : SARS-CoV-2; COVID-19; Convalescent plasma; Blood transfusion.

        · resumen en Español     · texto en Español     · Español ( pdf )